News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
718,424 Results
Type
Article (42491)
Company Profile (294)
Press Release (675639)
Multimedia
Podcasts (79)
Webinars (12)
Section
Business (210449)
Career Advice (2091)
Deals (36631)
Drug Delivery (107)
Drug Development (83057)
Employer Resources (175)
FDA (16577)
Job Trends (15410)
News (356063)
Policy (33922)
Tag
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
Academia (2598)
Accelerated approval (5)
Adcomms (21)
Allergies (90)
Alliances (51436)
ALS (92)
Alzheimer's disease (1397)
Antibody-drug conjugate (ADC) (132)
Approvals (16581)
Artificial intelligence (268)
Autoimmune disease (23)
Automation (16)
Bankruptcy (371)
Best Places to Work (11770)
BIOSECURE Act (20)
Biosimilars (111)
Biotechnology (188)
Bladder cancer (77)
Brain cancer (29)
Breast cancer (281)
Cancer (2290)
Cardiovascular disease (182)
Career advice (1752)
Career pathing (31)
CAR-T (152)
Cell therapy (429)
Cervical cancer (19)
Clinical research (67532)
Collaboration (855)
Compensation (530)
Complete response letters (25)
COVID-19 (2661)
CRISPR (46)
C-suite (248)
Cystic fibrosis (103)
Data (2211)
Decentralized trials (2)
Denatured (28)
Depression (45)
Diabetes (274)
Diagnostics (6452)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (111)
Drug shortages (28)
Duchenne muscular dystrophy (94)
Earnings (88292)
Editorial (38)
Employer branding (21)
Employer resources (149)
Events (115253)
Executive appointments (738)
FDA (17845)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (757)
Gene editing (111)
Generative AI (21)
Gene therapy (318)
GLP-1 (748)
Government (4538)
Grass and pollen (5)
Guidances (59)
Healthcare (18998)
Huntington's disease (24)
IgA nephropathy (28)
Immunology and inflammation (125)
Indications (30)
Infectious disease (2804)
Inflammatory bowel disease (140)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (98)
Interviews (322)
IPO (16785)
IRA (47)
Job creations (4057)
Job search strategy (1492)
Kidney cancer (10)
Labor market (38)
Layoffs (490)
Leadership (18)
Legal (8379)
Liver cancer (76)
Lung cancer (322)
Lymphoma (155)
Machine learning (7)
Management (59)
Manufacturing (318)
MASH (68)
Medical device (13461)
Medtech (13466)
Mergers & acquisitions (20385)
Metabolic disorders (706)
Multiple sclerosis (80)
NASH (17)
Neurodegenerative disease (93)
Neuropsychiatric disorders (29)
Neuroscience (1951)
NextGen: Class of 2025 (6637)
Non-profit (4528)
Now hiring (39)
Obesity (377)
Opinion (229)
Ovarian cancer (76)
Pain (95)
Pancreatic cancer (84)
Parkinson's disease (150)
Partnered (21)
Patents (239)
Patient recruitment (111)
Peanut (49)
People (59274)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20946)
Phase II (29711)
Phase III (22268)
Pipeline (1197)
Policy (151)
Postmarket research (2654)
Preclinical (8924)
Press Release (68)
Prostate cancer (107)
Psychedelics (31)
Radiopharmaceuticals (251)
Rare diseases (396)
Real estate (6258)
Recruiting (67)
Regulatory (23135)
Reports (46)
Research institute (2369)
Resumes & cover letters (358)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (76)
Series A (132)
Series B (85)
Service/supplier (12)
Sickle cell disease (55)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3726)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (43)
The Weekly (49)
Vaccines (706)
Venture capitalists (41)
Weight loss (253)
Women's health (35)
Worklife (16)
Date
Today (163)
Last 7 days (860)
Last 30 days (2665)
Last 365 days (33357)
2025 (10763)
2024 (35770)
2023 (40630)
2022 (51797)
2021 (56329)
2020 (54791)
2019 (47397)
2018 (35770)
2017 (33138)
2016 (32662)
2015 (38615)
2014 (32516)
2013 (27630)
2012 (29729)
2011 (30487)
2010 (28497)
Location
Africa (781)
Alabama (53)
Alaska (7)
Arizona (238)
Arkansas (14)
Asia (40722)
Australia (6521)
California (6137)
Canada (2020)
China (536)
Colorado (268)
Connecticut (273)
Delaware (149)
Europe (86938)
Florida (910)
Georgia (205)
Idaho (57)
Illinois (546)
India (26)
Indiana (315)
Iowa (11)
Japan (165)
Kansas (104)
Kentucky (23)
Louisiana (10)
Maine (62)
Maryland (895)
Massachusetts (4616)
Michigan (221)
Minnesota (391)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (63)
New Hampshire (63)
New Jersey (1737)
New Mexico (29)
New York (1746)
North Carolina (984)
North Dakota (8)
Northern California (2677)
Ohio (203)
Oklahoma (14)
Oregon (39)
Pennsylvania (1382)
Puerto Rico (12)
Rhode Island (33)
South America (1162)
South Carolina (22)
South Dakota (1)
Southern California (2300)
Tennessee (101)
Texas (913)
United States (23254)
Utah (182)
Virginia (153)
Washington D.C. (61)
Washington State (558)
West Virginia (3)
Wisconsin (56)
718,424 Results for "amphastar pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 7th, 2025
April 30, 2025
·
3 min read
Press Releases
Amphastar Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference
April 3, 2025
·
3 min read
Press Releases
Amphastar Pharmaceuticals to Present at the Barclays 27th Annual Global Healthcare Conference
March 5, 2025
·
3 min read
Biotech Beach
Amphastar Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
Amphastar Pharmaceuticals, Inc. will participate in an Analyst-Moderated fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 12:30 pm EST.
June 3, 2024
·
4 min read
Press Releases
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on February 27, 2025
February 21, 2025
·
3 min read
Business
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2024
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) (“Amphastar” or the “Company”) today reported results for the three months ended March 31, 2024.
May 8, 2024
·
14 min read
Press Releases
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2024
February 27, 2025
·
21 min read
Biotech Beach
Amphastar Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
Amphastar Pharmaceuticals, Inc. announced that Bill Peters, CFO, and Jacob Liawatidewi, EVP of Corporate Administration, will participate in an Analyst-Moderated fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 12:30 pm EST.
June 3, 2024
·
4 min read
Biotech Beach
Amphastar Announces Additional $50 Million Increase to its Share Buyback Program
Amphastar Pharmaceuticals, Inc. announced that on June 3, 2024, the Company’s Board of Directors authorized a $50 million increase to the Company’s share buyback program, which is expected to continue for an indefinite period of time.
June 4, 2024
·
4 min read
Press Releases
Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
·
3 min read
1 of 71,843
Next
